CMO Dr Pol Boudes on the innovation behind Galectin Therapeutics NASH cirrhosis clinical trial from part time job sites Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Pol Boudes0:08nI like to do things that have not been done before. And that's exactly what we are doing, and I like also to, to do things for patients so that you know we are kind of innovating. So I think it's very exciting, and then the science is exciting, and then the drug we are working with is, so we're trying to solve a problem that has never been solved before, and in that case it's a liver disease and it's cirrhosis, and it's been a neglected field for a long, long time, so it's kin
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)